Zemin Wang
- Cancer Research top 5%
- Carcinogens and Genotoxicity Assessment 7
- Immunology top 5%
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers 5
-
- Catalytic C–H Functionalization Methods 7
- Sulfur-Based Synthesis Techniques 6
-
- Mitochondrial Function and Pathology 7
- Genomics, phytochemicals, and oxidative stress 6
-
- Fluorine in Organic Chemistry 5
-
- Neuroscience and Neuropharmacology Research 5
- Co-authors
- James E. KlaunigXinzhu PuShaoyu ZhouClaire M. EdwardsJeannie F ToddMaryam MahmoudiStephen R. BloomM.A. Ghatei
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Angewandte Chemie International Edition (1 paper)Journal of Clinical Investigation (2 papers)
- Partner nations
- United StatesChinaFrance
In The Last Decade
Zemin Wang
101 papers receiving 3.6k citations
Peers
Comparison fields: 5 of 141
- Endocrinology, Diabetes and Metabolism 444
- Cancer Research 362
- Immunology 494
- Health, Toxicology and Mutagenesis 304
- Oncology 571
Countries citing papers authored by Zemin Wang
This map shows the geographic impact of Zemin Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zemin Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zemin Wang more than expected).
Fields of papers citing papers by Zemin Wang
This network shows the impact of papers produced by Zemin Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zemin Wang. The network helps show where Zemin Wang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Zemin Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2023 | 2 | |
| 3 | 2022 | 3 | |
| 4 | 2021 | 3 | |
| 5 | 2020 | 9 | |
| 6 | 2020 | 8 | |
| 7 | Comprehensive Analysis of Aberrantly Expressed Competitive Endogenous RNA Network and Identification of Prognostic Biomarkers in Pheochromocytoma and Paraganglioma | 2020 | 1 |
| 8 | 2019 | 26 | |
| 9 | 2019 | 33 | |
| 10 | 2019 | 14 | |
| 11 | Toxicity, biodistribution and oxidative damage caused by zirconia nanoparticles after intravenous injection | 2019 | 0 |
| 12 | 2019 | 59 | |
| 13 | 2019 | 7 | |
| 14 | 2017 | 1 | |
| 15 | 2017 | 40 | |
| 16 | 2017 | 68 | |
| 17 | 2017 | 14 | |
| 18 | A randomized placebo-controlled pilot study of N-acetylcysteine in youth with autism spectrum disorder | 2016 | 0 |
| 19 | 2015 | 7 | |
| 20 | 2011 | 95 |
About Zemin Wang
Zemin Wang is a scholar working on Pharmaceutical Science, Cancer Research and Oncology, having authored 106 papers that have together received 3.7k indexed citations. Recurring topics across this work include Catalytic C–H Functionalization Methods (7 papers), Carcinogens and Genotoxicity Assessment (7 papers), Mitochondrial Function and Pathology (7 papers), Genomics, phytochemicals, and oxidative stress (6 papers), Sulfur-Based Synthesis Techniques (6 papers), Fluorine in Organic Chemistry (5 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Neuroscience and Neuropharmacology Research (5 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (444 citations), Cancer Research (362 citations) and Immunology (494 citations). Zemin Wang has collaborated with scholars based in United States, China and France. Frequent co-authors include James E. Klaunig, Xinzhu Pu, Shaoyu Zhou, Claire M. Edwards, Jeannie F Todd, Maryam Mahmoudi, Stephen R. Bloom, M.A. Ghatei, S.R. Bloom and Mohammad A. Ghatei. Their work appears in journals such as Proceedings of the National Academy of Sciences, Angewandte Chemie International Edition and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.